[emphasis added] My non-patent-expert thinking in this regard is that Annora filed the Notice Letter because of its belief that the Challenged Patents which expire in 2039 include claims that ...

This chart summarizes the case name, drug, patents-in-suit, and publicly available terms for reported settlements in federal district court cases that are filed pursuant to the Hatch-Waxman Act.